Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and moraxella catarrhalis to 14 oral antibiotics

Journal of the Formosan Medical Association

Volumn 103, Issue 9, 2004, Pages 664-670

  Hsueh, Po Ren ^a   Huang, Wen Kuei ^b   Shyr, Jainn Ming ^c   Lau, Yeu Jun ^d   Liu, Yung Ching ^b   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Drug resistance, antimicrobial; Haemophilus influenzae; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFALEXIN; CEFIXIME; CEFPODOXIME; CEFRADINE; CEFUROXIME; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; PENICILLIN G; ANTIINFECTIVE AGENT;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; SPECIES DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TAIWAN; CLINICAL TRIAL; COMMUNICABLE DISEASE; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MICROBIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HAEMOPHILUS INFLUENZAE; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 7044239507     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Doern GV, Jones RN, Pfaller MA, et al: Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada). Antimicrob Agents Chemother 1999; 43:385-9.
2. Doern GV, Pfaller MA, Kugler K, et al: Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998; 27: 764-70.
3. Hsueh PR, Liu YC, Shyr JM, et al: Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan. Antimicrob Agents Chemother 2000;44:1342-5.
4. Hsueh PR, Liu CY, Luh KT: Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 2000;8:132-7.
5. Hsueh PR, Luh KT: Antimicrobial resistance in Streptococcus pneumoniae in Taiwan. Emerg Infect Dis 2002;8:1487-91.
6. Richter SS, Brueggemann AB, Huynh HK, et al: A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int J Antimicrob Agents 1999;13:99-107.
7. Schito GC, Georgopoulos A, Prieto J: Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. J Antimicrob Chemother 2002;50(Suppl):7-11.
8. Zhanel GG, Palatnick L, Nichol KA, et al: Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study. Antimicrob Agents Chemother 2003;47: 1875-81.
9. Hsueh PR, Teng LJ, Wu TL, et al: Telithromycin and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalences of resistance to macroides and β-lactams: data from the SMART program collected in 2001. Antimicrob Agents Chemother 2003;7:2145-51.
10. Hsueh PR, Chen HM, Huang AH, et al: Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995;61:3369-74.
11. Hsueh PR, Teng LJ, Lee LN, et al: Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol 1999;37:897-901.
12. Hsueh PR, Teng LJ, Lee LN, et al: Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M-phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb Drug Resist 2002;8:27-33.
13. Hsueh PR, Teng LJ, Lee CM, et al: Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: data from the SMART program, 2001. Antimicrob Agents Chemother 2003;7:2152-7.
14. Felmingham D: Review of the comparative in vitro activity of some oral cephalosporins. Infect Dis Clin Pract 1998;7:S75-S80.
15. National Committee for Clinical Laboratory Standards. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards-fifth edition. M7-A4. National Committee for Clinical Laboratory Standards; Wayne, PA.
16. National Committee for Clinical Laboratory Standards. (2003). Performance standards for antimicrobial susceptibility testing: twelfth informational supplement. M100-S13. National Committee for Clinical Laboratory Standards; Wayne, PA.
17. Cohen R: Clinical efficacy of cefpodoxime in respiratory tract infection. J Antimicrob Chemother 2002;50(Suppl):23-7.
18. Fulton B, Perry CM: Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Paediatr Drugs 2001;3:137-58.
19. Tsai HY, Huang LM, Chiu HH, et al: Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children. J Microbiol Immun Infect 1998;31:165-70.
20. Verhaegen J, Verbist L: In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1998;41: 381-5.
21. Zhanel GG, Palatnick L, Nichol KA, et al: Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study. Antimicrob Agents Chemother 2003;47:1867-74.
22. Liu YC, Huang WK, Cheng DL: Antibacterial activity of cefpodoxime in vitro. Chemotherapy 1997;43:21-6.